Delivery Order SPE2DB22D3501-SPE2DB25FUG75
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,682.54 fixed-price delivery order is for QUVIVIQ 25 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 6, 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB24FP79E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,238.99, is for the delivery of 4565592630 QUVIVIQ 25 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $1,341.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of pharmaceutical products, including the QUVIVIQ 50 MG TABLET 30S, to support military healthcare...
This contract award (SPE2DB20D2001|SPE2DB24FM48D) was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,053.91 firm fixed-price delivery order is for the supply of the drug Quviviq 25 MG Tablet, with a period of performance through March 6, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,516.74 Firm Fixed Price Delivery Order is for the supply of the prescription medication QUVIVIQ 25 MG TABLET 30S, with a completion date of June 21, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $1,324.19, is for the delivery of the prescription medication QUVIVIQ 25 MG TABLET 30S. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,021.66 firm fixed-price delivery order is for the provision of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,809.92 Firm Fixed Price Delivery Order is for the provision of the drug QUVIVIQ 25 MG TABLET 30S. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,079.18 firm fixed-price delivery order is for the supply of 4566566124 QULIPTA 60 MG TABLET 30S. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.79 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...